Icon

MILPROSA (nda201110)- (1.78GM)

PROGESTERONE FERRING PHARMS INC
1.78GM
No Yes
2030-Jan-21 Expired
None 2023-Apr-29
None No
MILPROSA is a progesterone indicated to support embryo implantation and early pregnancy (up to 10 weeks post-embryo transfer) by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment program for infertile women.
0 0 0
Total Other Developers None
Drugs with Suitability No
1.78GM ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.